Prognostic value of the H2 FPEF score in patients undergoing transcatheter aortic valve implantation.
Sebastian LudwigCostanza PellegriniAlina GosslingTobias RheudeLisa VoigtländerOliver D BhadraMatthias LinderDaniel KalbacherBenedikt KoellLara WaldschmidtJohannes SchirmerMoritz SeiffertHermann ReichenspurnerStefan BlankenbergDirk WestermannLenard ConradiMichael JonerNiklas SchoferPublished in: ESC heart failure (2020)
The H2 FPEF score serves as an independent predictor of adverse CV and heart failure outcome among TAVI patients with preserved EF. A high H2 FPEF score is associated with the presence of paradoxical low-flow, low-gradient AS, the HFpEF in patients with AS. By identifying patients in advanced stages of HFpEF, the H2 FPEF score might be useful as a risk prediction tool in patients with preserved EF scheduled for TAVI.
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve
- ejection fraction
- aortic valve replacement
- heart failure
- patients undergoing
- end stage renal disease
- transcatheter aortic valve replacement
- chronic kidney disease
- newly diagnosed
- left ventricular
- peritoneal dialysis
- prognostic factors
- patient reported outcomes
- adverse drug